GlaxoSmithKline PLC ADR (GSK) — Cash Flow Reinvestment Rate
GlaxoSmithKline PLC ADR (GSK) has a Cash Flow Reinvestment Rate of 0.40x as of March 2026, reinvesting $452.00 Million (capex $443.00 Million plus investments $9.00 Million) from operating cash flow of $1.14 Billion. Check GSK cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
GlaxoSmithKline PLC ADR Cash Flow Reinvestment Rate (1990–2025)
Historical reinvestment intensity for GlaxoSmithKline PLC ADR across 36 annual periods. Explore GlaxoSmithKline PLC ADR long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for GlaxoSmithKline PLC ADR (1990–2025)
Year-by-year capital reinvestment analysis for GlaxoSmithKline PLC ADR. For live market cap and broader valuation context, see GSK market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | $1.33 Billion | $7.14 Billion | $1.32 Billion | ▼ -71.0% |
| 2024 | 0.64x | $4.21 Billion | $6.55 Billion | $2.98 Billion | ▲ +57.0% |
| 2023 | 0.41x | $3.23 Billion | $7.89 Billion | $1.63 Billion | ▼ -72.5% |
| 2022 | 1.49x | $11.03 Billion | $7.40 Billion | $2.26 Billion | ▲ +262.9% |
| 2021 | 0.41x | $3.27 Billion | $7.95 Billion | $2.93 Billion | ▼ -21.2% |
| 2020 | 0.52x | $4.40 Billion | $8.44 Billion | $2.24 Billion | ▼ -44.4% |
| 2019 | 0.94x | $7.52 Billion | $8.02 Billion | $2.16 Billion | ▲ +135.7% |
| 2018 | 0.40x | $3.35 Billion | $8.42 Billion | $1.80 Billion | ▼ -24.5% |
| 2017 | 0.53x | $3.65 Billion | $6.92 Billion | $2.20 Billion | ▼ -5.5% |
| 2016 | 0.56x | $3.62 Billion | $6.50 Billion | $2.35 Billion | ▼ -86.1% |
| 2015 | 4.02x | $10.32 Billion | $2.57 Billion | $1.90 Billion | ▲ +1013.8% |
| 2014 | 0.36x | $1.87 Billion | $5.18 Billion | $1.75 Billion | ▲ +26.2% |
| 2013 | 0.29x | $2.06 Billion | $7.22 Billion | $1.70 Billion | ▼ -17.8% |
| 2012 | 0.35x | $1.52 Billion | $4.38 Billion | $1.52 Billion | ▲ +63.5% |
| 2011 | 0.21x | $1.33 Billion | $6.25 Billion | $1.33 Billion | ▼ -11.7% |
| 2010 | 0.24x | $1.64 Billion | $6.80 Billion | $1.64 Billion | ▲ +0.7% |
| 2009 | 0.24x | $1.87 Billion | $7.84 Billion | $1.87 Billion | ▼ -15.6% |
| 2008 | 0.28x | $2.07 Billion | $7.31 Billion | $2.07 Billion | ▼ -23.5% |
| 2007 | 0.37x | $2.14 Billion | $5.79 Billion | $2.14 Billion | ▼ -7.9% |
| 2006 | 0.40x | $1.59 Billion | $3.96 Billion | $1.59 Billion | ▲ +90.0% |
| 2005 | 0.21x | $1.18 Billion | $5.59 Billion | $1.18 Billion | ▲ +295.2% |
| 2004 | 0.05x | $255.00 Million | $4.77 Billion | $255.00 Million | ▼ -75.6% |
| 2003 | 0.22x | $1.06 Billion | $4.85 Billion | $1.06 Billion | ▼ -45.4% |
| 2002 | 0.40x | $1.23 Billion | $3.06 Billion | $1.23 Billion | ▲ +65.4% |
| 2001 | 0.24x | $1.12 Billion | $4.61 Billion | $1.12 Billion | ▼ -59.3% |
| 2000 | 0.60x | $1.10 Billion | $1.85 Billion | $1.10 Billion | ▼ -49.1% |
| 1999 | 1.17x | $597.00 Million | $510.00 Million | $597.00 Million | ▲ +1.0% |
| 1998 | 1.16x | $475.00 Million | $410.00 Million | $475.00 Million | ▲ +71.7% |
| 1997 | 0.67x | $415.00 Million | $615.00 Million | $415.00 Million | ▲ +42.9% |
| 1996 | 0.47x | $401.00 Million | $849.00 Million | $401.00 Million | ▼ -13.5% |
| 1995 | 0.55x | $684.00 Million | $1.25 Billion | $684.00 Million | ▲ +175.5% |
| 1994 | 0.20x | $485.59 Million | $2.45 Billion | $485.59 Million | ▼ -63.7% |
| 1993 | 0.55x | $575.00 Million | $1.05 Billion | $575.00 Million | ▼ -16.7% |
| 1992 | 0.66x | $608.00 Million | $927.00 Million | $608.00 Million | ▼ -27.5% |
| 1991 | 0.90x | $594.00 Million | $657.00 Million | $594.00 Million | ▼ -8.2% |
| 1990 | 0.99x | $606.00 Million | $615.00 Million | $606.00 Million | — |